StockData
Grifols SA logo

Grifols SA (GRFS) stock

GRFSNasdaqPharmaceutical PreparationsAlso trades as GIFLF, GIFOF, GIKLY
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 17, 2026Score 9/30
$8.73+0.04 (+0.46%)

Close on Nov 16, 2026Market cap $3.00BP/E 6.7Yield –

Grifols ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

For fiscal 2025 it was €1.69B, up 3.9% from the year before. Over ten years it grew 3.9% a year on average. The highest annual figure on record is €1.69B in fiscal 2025.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025€1.69B+3.9%
FY2024Dec 31, 2024€1.63B+32.7%
FY2023Dec 31, 2023€1.23B+2.9%
FY2022Dec 31, 2022€1.19B+25.0%
FY2021Dec 31, 2021€954.83M-27.5%
FY2020Dec 31, 2020€1.32B-8.1%
FY2019Dec 31, 2019€1.43B+17.3%
FY2018Dec 31, 2018€1.22B+0.3%
FY2017Dec 31, 2017€1.22B+6.8%
FY2016Dec 31, 2016€1.14B-1.6%
FY2015Dec 31, 2015€1.16B–

More Grifols figures

See a number that looks wrong?